R Leblay
- Genetics top 2%
- Oncology top 10%
- Molecular Biology
- Pathology and Forensic Medicine top 5%
- Hematology top 5%
- Co-authors
- R FauchetP. Y. LepriseJ ChaperonOlivier FardelJ GoasguenG. TertianBruno CazinBrigitte Dreyfus
- Topics
- Chronic Lymphocytic Leukemia Research (7 papers)Multiple Myeloma Research and Treatments (5 papers)Immunodeficiency and Autoimmune Disorders (3 papers)
- Partner nations
- FranceSwitzerlandTunisia
In The Last Decade
R Leblay
30 papers receiving 807 citations
Peers
Comparison fields: 5 of 64
- Genetics 380
- Oncology 294
- Molecular Biology 269
- Pathology and Forensic Medicine 263
- Hematology 229
Countries citing papers authored by R Leblay
This map shows the geographic impact of R Leblay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Leblay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Leblay more than expected).
Fields of papers citing papers by R Leblay
This network shows the impact of papers produced by R Leblay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Leblay. The network helps show where R Leblay may publish in the future.
Co-authorship network of co-authors of R Leblay
This figure shows the co-authorship network connecting the top 25 collaborators of R Leblay. A scholar is included among the top collaborators of R Leblay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Leblay. R Leblay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 323 | |
| 6 | 1 | |
| 7 | 18 | |
| 8 | [Epidermoid cyst of the spleen. 2 cases]. | 0 |
| 9 | 7 | |
| 10 | 192 | |
| 11 | 44 | |
| 12 | [Secondary paraneoplastic polycythemia of testicular cancer]. | 4 |
| 13 | [Splenectomy in the treatment of idiopathic thrombopenic purpura in adults. Apropos of 43 cases]. | 1 |
| 14 | 3 | |
| 15 | 3 | |
| 16 | Adherence properties of hairy cells. | 1 |
| 17 | [Pyoderma gangrenosum and chronic myeloïd leukemia. Two new cases (author's transl)]. | 1 |
| 18 | [Quantitation of myelofibrosis in blood diseases by electronic image analysis (author's transl)]. | 1 |
| 19 | [Renal lesions in myelofibrosis (author's transl)]. | 2 |
| 20 | Maladie de Hodgkin: étude de l'hypersensibilité retardée de 64 malades non traités. Intérêt du test épicutané à l'huile de croton | 1 |
About R Leblay
R Leblay is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 31 papers that have together received 832 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Multiple Myeloma Research and Treatments (5 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Genetics (380 citations), Hematology (229 citations) and Pathology and Forensic Medicine (263 citations). R Leblay has collaborated with scholars based in France, Switzerland and Tunisia. Frequent co-authors include R Fauchet, P. Y. Leprise, J Chaperon, Olivier Fardel, J Goasguen, G. Tertian, Bruno Cazin, Brigitte Dreyfus, Karim Maloum and J. Jaubert. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.